93
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients

ORCID Icon, , , , , , , , , & show all
Pages 1135-1141 | Received 21 Feb 2023, Accepted 01 Sep 2023, Published online: 11 Sep 2023

References

  • Wunderink RG. Nosocomial pneumonia, including ventilator-associated pneumonia. Proc Am Thorac Soc. 2005;2(5):440–444. doi: 10.1513/pats.2005080-83JS
  • Martin-Loeches I, Depuydt P, Niederman MS. Beat around the bush for VA-LRTI. Intensive care Med. 2018 Nov;44(11):1961–1963. doi: 10.1007/s00134-018-5281-y
  • Martin-Loeches I, Povoa P, Rodríguez A, et al. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study. Lancet Respir Med. 2015 Nov;3(11):859–868. doi: 10.1016/S2213-2600(15)00326-4
  • Nseir S, Povoa P, Salluh J, et al. Is there a continuum between ventilator-associated tracheobronchitis and ventilator-associated pneumonia? Intensive care Med. 2016 Jul;42(7):1190–1192. doi: 10.1007/s00134-016-4283-x
  • Keane S, Vallecoccia MS, Nseir S, et al. How can we distinguish ventilator-associated tracheobronchitis from pneumonia? Clin Chest Med. 2018 Dec;39(4):785–796. doi: 10.1016/j.ccm.2018.08.003
  • Roquilly A, Jacqueline C, Davieau M, et al. Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis. Nat Immunol. 2020 Jun;21(6):636–648. doi: 10.1038/s41590-020-0673-x
  • Almansa R, Nogales L, Martín-Fernández M, et al. Transcriptomic depression of immunological synapse as a signature of ventilator-associated pneumonia. Ann translat Med. 2018;6(21):415. doi: 10.21037/atm.2018.05.12
  • Tremblay JA, Peron F, Kreitmann L, et al. A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score. Ann Intensive Care. 2022 Aug 17;12(1):76. doi: 10.1186/s13613-022-01051-3
  • Monneret G, Gossez M, Venet F. Sepsis and immunosenescence: closely associated in a vicious circle. Aging Clin Exp Res. 2021 Mar;33(3):729–732. doi: 10.1007/s40520-019-01350-z
  • Monneret G, Lepape A, Venet F. A dynamic view of mHLA-DR expression in management of severe septic patients. Crit Care. 2011;15(5):198. doi: 10.1186/cc10452
  • Remy S, Gossez M, Belot A, et al. Massive increase in monocyte HLA-DR expression can be used to discriminate between septic shock and hemophagocytic lymphohistiocytosis-induced shock. Crit Care. 2018 Sep 11;22(1):213. doi: 10.1186/s13054-018-2146-2
  • Venet F, Rimmelé T, Monneret G. Management of sepsis-induced immunosuppression. Crit Care Clin. 2018 Jan;34(1):97–106. doi: 10.1016/j.ccc.2017.08.007
  • Bodinier M, Peronnet E, Brengel-Pesce K, et al. Monocyte trajectories endotypes are associated with worsening in septic patients. Front Immunol. 2021;12:795052. doi: 10.3389/fimmu.2021.795052
  • Klompas M. Is a ventilator-associated pneumonia rate of zero really possible? Curr Opin Infect Dis. 2012 Apr;25(2):176–182. doi: 10.1097/QCO.0b013e3283502437
  • Hurley JC. Candida and the Gram-positive trio: testing the vibe in the ICU patient microbiome using structural equation modelling of literature derived data. Emerg Themes Epidemiol. 2022 Aug 18;19(1):7. doi: 10.1186/s12982-022-00116-9
  • Martin-Loeches I, Coakley JD, Nseir S. Should we treat ventilator-associated tracheobronchitis with antibiotics? Semin Respir Crit Care Med. 2017 Jun;38(3):264–270. doi: 10.1055/s-0037-1602582
  • Liu Z, Liu S, Zhang Y, et al. Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production. Cell Immunol. 2021 Oct 01;368:104420.
  • Speiser DE, Migliaccio M, Pittet MJ, et al. Human CD8+ T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells. Eur J Immunol. 2001;31(2):459–466. doi: 10.1002/1521-4141(200102)31:2<459:AID-IMMU459>3.0.CO;2-Y
  • Koch RM, Kox M, de Jonge MI, et al. Patterns in bacterial- and viral-induced immunosuppression and secondary infections in the ICU. Shock. 2017;47(1):5–12. doi: 10.1097/SHK.0000000000000731
  • Martin-Loeches I, Levy MM, Artigas A. Management of severe sepsis: advances, challenges, and current status. Drug Des Devel Ther. 2015;9:2079–2088. doi: 10.2147/DDDT.S78757
  • Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013 Dec;13(12):862–874. doi: 10.1038/nri3552
  • Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013 Mar;13(3):260–268. doi: 10.1016/S1473-3099(13)70001-X
  • Payen D, Monneret G, Hotchkiss R. Immunotherapy - a potential new way forward in the treatment of sepsis. Crit Care. 2013 Feb 20;17(1):118. doi: 10.1186/cc12490
  • Venet F, Lukaszewicz AC, Payen D, et al. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol. 2013 Aug;25(4):477–483. doi: 10.1016/j.coi.2013.05.006
  • Martinez GS, Pérez-Rueda E, Sarkar S, et al. Machine learning and statistics shape a novel path in archaeal promoter annotation. BMC Bioinf. 2022 May 10;23(1):171. doi: 10.1186/s12859-022-04714-x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.